Nov 15, 2013 -
SWOG members have expressed a desire to know what's going on within the Group, as well as finding out what our experts think is important, culled from the broader world of oncology research and treatment. Many of our new communications reflect this, including this weekly blog and the Twitter postings that SWOG members and partners contribute every day.
The latter are links to items from across the Web that are of great interest to cancer researchers. These experts and organizations collectively provide enormous value in curating online content, linking us to high quality, authoritative news and information targeted to our areas of professional interest and concern.
We've explored a way to distill that value for timely and easy distribution to all SWOG members, through the use of an online service that aggregates some of the most valuable of this curated content and presents it in a "newspaper" format. And so we introduce The SWOG Cancer Research Daily
, a compendium of news of, by, and for SWOG members, sites, patients, and partners, available at swog.org/media/daily
You can subscribe to The Daily
by clicking the "Share" button in the newspaper's right column. By subscribing, you'll get the lead story and a link to the full edition in your inbox every morning. If you follow the @SWOG Twitter account
, you'll see a tweet go by every morning announcing that the latest edition is available and providing a link.
The select list of sources The Daily
draws from features a number of SWOG researchers, but also professional organizations (example: @ASCO
), member site newsrooms (example: @MDAndersonNews
), journals (example: @JNCI_Now
), patient advocates and advocacy organizations (example: @SWOGAdvocate
), and more. We'll keep working at refining the list of sources and the filters applied to those sources to ensure that only the most useful and authoritative content makes it into The Daily
. You can help by sending us feedback on what you find valuable in the publication and what else you would like to see.